To include your compound in the COVID-19 Resource Center, submit it here.

Extina 2% ketoconazole: Phase IIIa

CNCT said that in an 50-patient U.S. Phase IIIa

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE